The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro

Leo Hofland, J Hoek, P Koetsveld, W.W. de Herder, Marlijn Waaijers, DM Sprij-Mooij, C Bruns, G Weckbecker, R.A. Feelders, AJ (Aart-Jan) van der Lely, A Beckers, S.W.J. Lamberts

Research output: Contribution to journalArticleAcademicpeer-review

177 Citations (Scopus)
15 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1577-1585
Number of pages9
JournalJournal of Clinical Endocrinology and Metabolism
Volume89
Issue number4
DOIs
Publication statusPublished - 2004

Research programs

  • EMC MM-01-39-01

Cite this